Clinical Trial Update: Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis [NA]

View source ↗

Summary

Clinical trial update on the completion of a study evaluating whether consuming Lactobacillus GG and fructooligosaccharides affects immune responses in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• Fructooligosaccharides (FOS) (Fructooligosaccharides)
• Lactobacillus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Sprim Advanced Life Sciences | Conditions: Herpes Labialis | NA | Status: COMPLETED